Abstract
Large cohort studies on whether any association existed between urological interventions for urolithiasis and the development of CKD are lacking. From claims data of the National Health Insurance (NHI) program of Taiwan, we identified 54,433 patients newly diagnosed with urolithiasis during 1998–2010. For each case, four individuals without urolithiasis were randomly selected and frequency matched by age, sex, and diagnosis year. Both groups were followed up until the end of 2010. Incident CKD events were identified by the International Classification of Diseases, Ninth Revision (ICD-9) code in the NHI registration database. The overall incidence of periodontal diseases was 1.85-fold greater in the urolithiasis group than in the comparison group (33.9 vs 18.3 per 10,000 person-years; 95 % confidence interval [CI] 1.81–1.90). Compared with the adjusted hazard ratios (aHRs) of nonurolithiasis patients, those of patients with urolithiasis increased with the number of medical visits (from 0.91 [95 % CI 0.83–1.00] to 10.6 [95 % CI 9.48–11.8]) and urological interventions (from 1.22 [95 % CI 1.10–1.35] to 86.4 [95 % CI 67.6–110.6]). The aHR was similar in different urological intervention methods, extracorporeal shock wave lithotripsy, ureteroscopy, percutaneous nephrostolithotomy, and open stone surgery. The urological intervention for urolithiasis is associated with an increased risk of CKD. We should be aware of the risk for CKD, especially in patients who have received multiple urological interventions and those elderly.
Similar content being viewed by others
Abbreviations
- aHR:
-
Adjusted hazard ratio
- CI:
-
Confidence interval
- CKD:
-
Chronic kidney disease
- ESRD:
-
End-stage renal disease
- ICD-9-CM:
-
International Classification of Diseases, Ninth Revision, Clinical Modification
- NHIRD:
-
National Health Insurance Research Database
- LHID 2000:
-
Longitudinal Health Insurance Database 2000
References
Yasui T, Iguchi M, Suzuki S, Kohri K (2008) Prevalence and epidemiological characteristics of urolithiasis in Japan: national trends between 1965 and 2005. Urology 71(2):209–213
Safarinejad MR (2007) Adult urolithiasis in a population-based study in Iran: prevalence, incidence, and associated risk factors. Urol Res 35(2):73–82
Hesse A, Brändle E, Wilbert D, Köhrmann K-U, Alken P (2003) Study on the prevalence and incidence of urolithiasis in Germany comparing the years 1979 vs. 2000. Eur Urol 44(6):709–713
Knoll T (2010) Epidemiology, pathogenesis, and pathophysiology of urolithiasis. Eur Urol Suppl 9(12):802–806
Brikowski TH, Lotan Y, Pearle MS (2008) Climate-related increase in the prevalence of urolithiasis in the United States. Proc Natl Acad Sci 105(28):9841–9846
Fink HA, Akornor JW, Garimella PS, MacDonald R, Cutting A, Rutks IR, Monga M, Wilt TJ (2009) Diet, fluid, or supplements for secondary prevention of nephrolithiasis: a systematic review and meta-analysis of randomized trials. Eur Urol 56(1):72–80
Pearle MS, Calhoun EA, Curhan GC, Project UDoA (2005) Urologic diseases in America project: urolithiasis. J Urol 173(3):848–857
Skolarikos A, Alivizatos G, de la Rosette J (2006) Extracorporeal shock wave lithotripsy 25 years later: complications and their prevention. Eur Urol 50(5):981–990
Paryani JP, Ather MH (2002) Improvement in serum creatinine following definite treatment of urolithiasis in patients with concurrent renal insufficiency. Scand J Urol Nephrol 36(2):134–136
Lifshitz DA, Lingeman JE, Zafar FS, Hollensbe DW, Nyhuis AW, Evan AP (1998) Alterations in predicted growth rates of pediatric kidneys treated with extracorporeal shockwave lithotripsy. J Endourol Soc 12(5):469–475
Willis LR, Evan AP, Connors BA, Blomgren P, Fineberg NS, Lingeman JE (1999) Relationship between kidney size, renal injury, and renal impairment induced by shock wave lithotripsy. J Am Soc Nephrol CJASN 10(8):1753–1762
Goel MC, Baserge NS, Babu RV, Sinha S, Kapoor R (1996) Pediatric kidney: functional outcome after extracorporeal shock wave lithotripsy. J Urol 155(6):2044–2046
Traxer O, Lottmann H, Archambaud F, Helal B, Mercier-Pageyral B (1999) Extracorporeal lithotripsy in children. Study of its efficacy and evaluation of renal parenchymal damage by DMSA-Tc 99 m scintigraphy: a series of 39 children. Arch de pediatrie : organe officiel de la Societe francaise de pediatrie 6(3):251–258
El-Zoghby ZM, Lieske JC, Foley RN, Bergstralh EJ, Li X, Melton LJ 3rd, Krambeck AE, Rule AD (2012) Urolithiasis and the risk of ESRD. Clin J Am Soc Nephrol CJASN 7(9):1409–1415
Kummer AE, Grams M, Lutsey P, Chen Y, Matsushita K, Kottgen A, Folsom AR, Coresh J (2015) Nephrolithiasis as a Risk Factor for CKD: The Atherosclerosis Risk in Communities Study. Clin J Am Soc Nephrol CJASN 10(11):2023–2029
Gillen DL, Worcester EM, Coe FL (2005) Decreased renal function among adults with a history of nephrolithiasis: a study of NHANES III. Kidney Int 67(2):685–690
Ophascharoensuk V, Giachelli CM, Gordon K, Hughes J, Pichler R, Brown P, Liaw L, Schmidt R, Shankland SJ, Alpers CE (1999) Obstructive uropathy in the mouse: role of osteopontin in interstitial fibrosis and apoptosis. Kidney Int 56(2):571–580
Saucier NA, Sinha MK, Liang KV, Krambeck AE, Weaver AL, Bergstralh EJ, Li X, Rule AD, Lieske JC (2010) Risk factors for CKD in persons with kidney stones: a case-control study in Olmsted County, Minnesota. Am J Kidney Dis 55(1):61–68
Khosla UM, Zharikov S, Finch JL, Nakagawa T, Roncal C, Mu W, Krotova K, Block ER, Prabhakar S, Johnson RJ (2005) Hyperuricemia induces endothelial dysfunction. Kidney Int 67(5):1739–1742
Alexander RT, Hemmelgarn BR, Wiebe N, Bello A, Samuel S, Klarenbach SW, Curhan GC, Tonelli M (2014) Kidney stones and cardiovascular events: a cohort study. Clin J Am Soc Nephrol 9(3):506–512
Gambaro G, Favaro S, D’Angelo A (2001) Risk for renal failure in nephrolithiasis. Am J Kidney Dis 37(2):233–243
Stankus N, Hammes M, Gillen D, Worcester E (2007) African American ESRD patients have a high pre-dialysis prevalence of kidney stones compared to NHANES III. Urol Res 35(2):83–87
Siegel C (2012) Re: Clinical characteristics of potential kidney donors with asymptomatic kidney stones. J Urol 188(3):849–850
Strang AM, Lockhart ME, Amling CL, Kolettis PN, Burns JR (2008) Living renal donor allograft lithiasis: a review of stone related morbidity in donors and recipients. J Urol 179(3):832–836
Alexander RT, Hemmelgarn BR, Wiebe N, Bello A, Morgan C, Samuel S, Klarenbach SW, Curhan GC, Tonelli M (2012) Kidney stones and kidney function loss: a cohort study. BMJ 345:e5287–e5294
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding
This study is supported in part by Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW105-TDU-B-212-133019), China Medical University Hospital, Academia Sinica Taiwan Biobank Stroke Biosignature Project (BM10501010037), NRPB Stroke Clinical Trial Consortium (MOST 105-2325-B-039-003), Tseng-Lien Lin Foundation, Taichung, Taiwan, Taiwan Brain Disease Foundation, Taipei, Taiwan, and Katsuzo and Kiyo Aoshima Memorial Funds, Japan.
Conflict of interest
The authors declare no conflicts of interest.
Ethnic approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. This study was approved by the Ethics Review Board of China Medical University (CMUH104-REC2-115).
Informed consent
Because NHIRD database was de-identification, thus this study was exempted from informed consent.
Rights and permissions
About this article
Cite this article
Lin, SY., Lin, CL., Chang, CH. et al. Comparative risk of chronic kidney diseases in patients with urolithiasis and urological interventions: a longitudinal population-based study. Urolithiasis 45, 465–472 (2017). https://doi.org/10.1007/s00240-016-0929-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00240-016-0929-y